Indian Repaglinide Exporters: Complete Supplier Ranking with Market Share — 112 Manufacturers (2026) — TransData Nexus

Q: Who is the largest repaglinide buyer importing from India?

AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES) is the largest repaglinide importer from India with a 7.4% market share and import value of $511.2K.

Q: How many repaglinide buyers import from India?

There are 112 active repaglinide buyers importing from India, with a combined import market of $6.9M across 819 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top repaglinide buyers from India?

The top 5 repaglinide buyers — AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC, (AUROBINDO PHARM, RISING PHARMA HOLDINGS INC, AUROLOGISTICS LLC(AUROBINDO PHARMA, RISING PHARMA HOLDINGS, INC. ,. — together control 34.3% of total repaglinide import value from India.

Suresh Sormare

Repaglinide

India Pharmaceutical Trade Intelligence

$6.9M41 Suppliers36 CountriesHS 30049099

ExportsIndia → UNITED STATES60.4%India → FRANCE15.7%

ImportsGERMANY → India$167.2M DENMARK → India$185.9K

#1 Buyer: AUROLOGISTICS LLC

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $4.2M through 116 shipments. This represents a market share of 60.4% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• AUROLOGISTICS LLC (AUROBINDO PHARMA - $511.2K (12.2% of country's total business)

• AUROLOGISTICS LLC, (AUROBINDO PHARM - $483.3K (11.6% of country's total business)

• RISING PHARMA HOLDINGS INC - $463.1K (11.1% of country's total business)

• AUROLOGISTICS LLC(AUROBINDO PHARMA - $461.1K (11.0% of country's total business)

• RISING PHARMA HOLDINGS, INC. ,. - $452.3K (10.8% of country's total business)

• Rest of United States's importers - $1.8M (43.2% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $36.0K, indicating premium pricing strategy compared to the market average of $8.4K.

United States is a key market for Repaglinide imports, representing 60.4% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Repaglinide buyer market intelligence

1Buyer Segment Analysis

Repaglinide, an antidiabetic medication, is imported from India by various entities, primarily classified into the following segments:

1. Distributors: These entities purchase large quantities of Repaglinide to supply to pharmacies, hospitals, and other healthcare providers. Their buying behavior is characterized by bulk orders and regular procurement schedules to maintain a steady supply chain. In our data, AUROLOGISTICS LLC (AUROBINDO PHARMA) in the United States, with imports totaling $0.51 million, exemplifies this category.

2. Contract Manufacturers: These companies import Repaglinide as an active pharmaceutical ingredient (API) to produce finished dosage forms. Their procurement patterns depend on production schedules and demand forecasts. RISING PHARMA HOLDINGS INC in the United States, importing $0.46 million worth of Repaglinide, falls into this segment.

3. Re-exporters: Some buyers import Repaglinide with the intent to re-export to other markets, often after repackaging or further processing. Their purchasing behavior is influenced by global market demands and regulatory considerations. ARROW GENERIQUES in France, with imports totaling $0.34 million, is indicative of this segment.

The high repeat buyer rate of 79.5% suggests strong, ongoing relationships between Indian exporters and these buyers, reflecting consistent demand and satisfaction with the product quality and supply reliability.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Repaglinide buyer market intelligence

1Country-Specific Import Regulations

Importing Repaglinide into the top five importing countries involves adherence to specific regulatory frameworks:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: Foreign drug manufacturers must register with the FDA and list their products. Each drug must have an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Importers must file an entry notice with U.S. Customs and Border Protection, and the FDA verifies compliance upon importation.

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

2. France:

Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).

Demand Drivers & Market Opportunity

TransData Nexus Repaglinide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Repaglinide in importing countries is driven by several factors:

1. Disease Prevalence: Type 2 diabetes mellitus (T2DM) is a significant public health concern globally. According to the World Health Organization (WHO), the prevalence of diabetes has been steadily increasing, with an estimated 422 million adults affected worldwide as of 2025. This rising prevalence directly correlates with increased demand for antidiabetic medications like Repaglinide.

2. Government Healthcare Programs: Many countries have implemented national health programs aimed at managing chronic diseases, including diabetes. For instance, Canada's public healthcare system covers prescription medications for eligible populations, facilitating access to essential drugs. Similarly, France's Assurance Maladie provides reimbursement for diabetes treatments, ensuring patient access to necessary medications.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led to increased access to essential medicines. Countries like Vietnam have been expanding their UHC schemes, resulting in greater availability and affordability of medications for chronic conditions.

4. WHO Essential Medicines List Procurement: The inclusion of antidiabetic drugs in the WHO Essential Medicines List encourages countries to prioritize their procurement and distribution. This inclusion supports the availability of medications like Repaglinide in public health systems.

5. Tender-Based Purchasing: Many governments and healthcare institutions utilize tender systems to procure pharmaceuticals, ensuring cost-effective and large-scale acquisition of essential medicines. This approach often leads to stable demand for drugs like Repaglinide, as suppliers compete to fulfill substantial orders.

Common Questions — Repaglinide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest repaglinide buyer importing from India?

Based on import volume and value, AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES) leads with $511.2K in imports and a 7.4% market share — the highest of any single repaglinide importer. AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) and RISING PHARMA HOLDINGS INC (UNITED STATES) are the next largest buyers.

QHow many companies buy repaglinide from India?

There are 112 active repaglinide buyers importing from India, with a combined market of $6.9M across 819 shipments to 36 countries. The top 5 buyers hold 34.3% of total import value, while the remaining 107 buyers handle the other 65.7%.

QWhich countries import the most repaglinide from India?

The top importing countries for repaglinide from India are United States (60.4%), France (15.7%), Canada (7.3%), Vietnam (3.9%), Croatia (3.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of repaglinide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for repaglinide from India?

The average import transaction value for repaglinide from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Repaglinide buyer market intelligence

1Buyer Segment Analysis

Repaglinide, an antidiabetic medication, is imported from India by various entities, primarily classified into the following segments:

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Repaglinide buyer market intelligence

1Country-Specific Import Regulations

Importing Repaglinide into the top five importing countries involves adherence to specific regulatory frameworks:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

2. France:

Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).

Demand Drivers & Market Opportunity

TransData Nexus Repaglinide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Repaglinide in importing countries is driven by several factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Repaglinide

Repaglinide

Who Buys Repaglinide from India — 112 Importers Behind a $6.9M Market

Top Repaglinide Importers — Ranked by Import Value

Top Repaglinide Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Repaglinide — and from which countries?

Repaglinide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Repaglinide Buyers & Importers

QWho is the largest repaglinide buyer importing from India?

QHow many companies buy repaglinide from India?

QWhich countries import the most repaglinide from India?

QWhat is the average import order value for repaglinide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2France

3Canada

4Vietnam

5Croatia

Analysis Methodology